BSBurcu Karpuz Seren

Burcu Karpuz Seren

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Burcu Karpuz Seren has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Integrating Precision Medicine into Clinical Practice

    by Burcu Karpuz Seren

    Management of non-motor symptoms such as headache and sleep disturbances in neurodegenerative diseases requires consideration of individual genetic and environmental variability, beyond classical therapeutic approaches. Precision medicine has rapidly advanced through multi-omic strategies, including genomics, transcriptomics, proteomics, and metabolomics, as well as digital health technologies and artificial intelligence (AI)–based analytics. In clinical decision-making, biomarker-driven algorithms and AI-assisted digital monitoring systems provide high effectiveness in early diagnosis and risk stratification. Through this integrated approach, pharmacogenetic profiling together with digital self-management tools may improve treatment effectiveness, support adherence, and help to minimize unnecessary medication use. As precision medicine becomes more widely incorporated, therapeutic models that are more adaptable and clinically sustainable are likely to develop for the management of neurodegenerative diseases.

  • Association between lipid profile, atherogenic index, and cognitive function in Alzheimer’s disease: A retrospective cohort study

    by Burcu Karpuz Seren, Filiz Dilek, Bengü Altunan, Aysun Ünal

    Aim: This study aimed to investigate the relationship between lipid profile parameters (including the atherogenic index of plasma (AIP)) and cognitive function in patients diagnosed with Alzheimer’s disease (AD), based on Mini-Mental State Examination (MMSE) scores measured at the same visit and after a two-year follow-up period.Material and Methods: This retrospective study included patients followed at the Dementia Outpatient Clinic of University Hospital between 2016 and 2025. A total of 84 AD patients with simultaneous lipid profile measurements (total cholesterol [TC], low-density lipoprotein [LDL], high-density lipoprotein [HDL], triglycerides [TG]) and MMSE scores were included. Among them, 41 patients had a second MMSE recorded two years later. AIP was calculated using the logarithmic formula log(TG/HDL). Additional ratios including LDL/HDL, TC/HDL, non-HDL cholesterol, and TG/HDL were also analyzed. Correlation analyses were performed using Pearson or Spearman tests depending on data distribution, with statistical significance set at p

  • Alzheimer Hastalığı Tedavisi

    by Mustafa Tarakcı, Burcu Karpuz Seren

    Alzheimer Hastalığı (AH), patolojik olarak nöronal kayıp, amiloid-beta (Aβ) plaklarının ve hiperfosforile tau nörofibriler yumaklarının (NFY'ler) birikimiyle karakterize, ilerleyici bir nörodejeneratif bozukluktur. Mevcut farmakolojik yönetim, bilişsel işlevi artıran veya eksitotoksisiteyi azaltan asetilkolinesteraz inhibitörü Donepezil ve NMDA reseptör antagonisti Memantin gibi semptomatik tedavileri içermektedir. Son terapötik gelişmeler, temel patolojiyi hedefleyen hastalığı modifiye edici tedavilere (HMT'ler) odaklanmaktadır. Donanemab ve Lecanemab gibi monoklonal antikorlar, Aβ plaklarını temizleyerek erken evre AH'de klinik gerilemeyi önemli ölçüde yavaşlatarak etkinlik göstermektedir. Ancak, bu immünoterapiler, özellikle Amiloidle İlişkili Görüntüleme Anormallikleri (ARIA) gibi risklerle ilişkilidir. Gelişmekte olan stratejiler, uygun bir mikroçevreyi teşvik etmek, kaybedilen nöronları ikame etmek ve toksik agregatları temizlemek amacıyla Embriyonik, Mezenkimal, Nöral ve İndüklenmiş Pluripotent Kök Hücreleri (iPKH) kullanan kök hücre tedavilerini kapsamaktadır. Ayrıca, kapsamlı tedavi nöropsikiyatrik semptomları da ele almaktadır: ajitasyon, öncelikli olarak farmakolojik olmayan yöntemler veya Brexpiprazole ile, depresyon ise sıklıkla essitalopram gibi SSRI'lara yanıt vermektedir. Bu yeni tedavilerin sürdürülebilir etkinliğini ve güvenlik profillerini belirlemek için devam eden uzun vadeli çalışmalar hayati önem taşımaktadır.

  • Open Access

    Fear of Movement: Validity and Reliability Study of the Turkish Version of the Tampa Scale of Kinesiophobia for Headache in Patients with Migraine

    by Dilara Onan, Halime Arıkan, Doğa Vurallı, Merve Ceren Akgör, Ayşenur Başel Pala, Ece Yanık, Ayşe İrem Can, Can Ulutaş, Pelin Yenilmez Yeşildaş, Burcu Karpuz Seren, et al.

    While triggering by physical activity is a criterion for the diagnosis of migraine, evaluations regarding fear of movement related to physical activity are lacking in the literature. This study aimed to investigate the validity and reliability of the Turkish version of the Tampa Scale of Kinesiophobia, adapted to headache (TSK-H), in patients with episodic migraine (EM) and chronic migraine (CM). This questionnaire is a newly developed version adapted for headache, based on but different from the original TSK used in low back pain, and has not been previously validated in Turkish for headache. Patients between the ages of 18–70 were included in the study. Demographic-clinical information was obtained after expert committee evaluation and cross-cultural adaptation of the questionnaire. Numerical Pain Rating Scale (NPRS), Migraine Disability Assessment (MIDAS), Headache Impact Test-6 (HIT-6), Hospital Anxiety and Depression Scale (HADS) and TSK-H were evaluated for structural validity. Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) were performed. Intraclass Correlation Coefficient (ICC) and Cronbach’s α values ​​were analyzed for reliability. A total of 329 patients (n = 148 EM, n = 181 CM) with a mean age of 37.2 ± 10.6 years for EM and 39.8 ± 13.1 years for CM were included in the study. Headache intensity on NPRS was 6.89 ± 1.86 for EM and 7.56 ± 2.10 for CM. Item-total correlations ranged from − 0.030 to 0.758. Cronbach’s α was 0.925. TSK-H had good test-retest reliability (ICC = 0.866, n = 151) and high internal consistency (Cronbach’s α = 0.928). TSK-H was associated with NPRS, MIDAS, HIT-6 and HADS (p < 0.000 for each one). EFA identified a four-factor structure explaining 58.64% of the variance. CFA remained within acceptable limits. The Turkish version of the 23-item TSK-H is a valid and reliable tool for assessing kinesiophobia in patients with migraine and is significantly associated with physical, functional and psychosocial factors.


  • Open Access

    Coexistence Of Corpus Callosum Splenium Infarct And COVID-19 Pneumonia: A Case Report

    by Burcu Karpuz Seren, Orbay Tutku Seren, Hüseyin Tuğrul Atasoy

    In this article, we presented our case who developed CC splenium infarction who had COVID-19 pneumonia at the same time. A 45-year-old male patient with a positive COVID-19 PCR test was admitted to the emergency department with complaints of confusion and loss of direction. He didn’t have a chronic disease, a history of smoking and alcohol abuse. Confusion was found on mental examination. The Splenium of the CC was hyperintense on diffusion-weighted magnetic resonance imaging (MRI) and hypointense on Apparent diffusion coefficient (ADC) sequence. There are a few case reports in the literature about young patients who do not have known or unexplained cardiovascular risk factors and who have had COVID-19-related pneumonia. We thought that COVID-19 pneumonia might be a triggering factor since infarction of the splenium region of the corpus callosum is rare, the patient is in the young age patient group, and there is no other comorbidity.

  • Open Access

    Relationship between the severity of carpal tunnel syndrome and lipid profile in patients with tip 2 diabetes mellitus

    by Esra Aci̇mAn Demi̇rEl, Burcu Karpuz, Mustafa Açikgöz, Hüsyin Tuğrul ATASOY

    Background/Aim: Diabetes mellitus (DM) accelerates the development of neuropathy, and carpal tunnel syndrome (CTS) is the most common form of entrapment neuropathy. The pathogenesis of diabetic neuropathy is multifactorial with its vascular and metabolic factors. In this study, we aimed to evaluate the relationship among the electrophysiological severity of CTS, lipid profile and serum atherogenic index in patients with Type 2 DM. Methods: In this hospital-based retrospective cross-sectional study, we retrospectively evaluated 202 type 2 DM patients, who presented to the electrophysiology laboratory of Zonguldak Bulent Ecevit University Faculty of Medicine between 2016-2019 and investigated the relationship among the electrophysiological severity of CTS, lipid profile and serum atherogenic index of 131 patients diagnosed with CTS. Results: The patients with CTS had significantly higher values of fasting blood glucose and HbA1c compared to those without CTS (P=0.010). In terms of the severity of CTS, the patients were divided into three groups as mild, moderate, severe. In terms of the lipid panel, the mean values of cholesterol, triglyceride, and HDL-C were similar among the groups (P=0.098, P=0.321, P=0.706), while LDL-C levels were higher in the severe CTS group. (P=0.024). There was a significant positive correlation between age (R=0.126 P=0.004), HbA1c (R=0.245, P=0.002) and CTS severity. Conclusion: We identified a relationship between CTS severity and LDL-C. CTS should be considered in patients with DM and hyperlipidemia. Further larger-scale studies with control groups are recommended.


  • Risk Factors for Diabetic Polyneuropathy

    by Esra Aci̇man Demi̇rel, Burcu Karpuz, Ulufer Çelebi̇, Mustafa Açikgöz, Hüsyin Tuğrul ATASOY

    Objective: Diabetes Mellitus is one of the most common metabolic diseases. The most frequent complication of DM is diabetic polyneuropathy. Diabetic polyneuropathy is related to high mortality, morbidity, hospitalization rate and serious level of economic burden. We aimed in this study to determine the risk factors that affect DPN pathology. Methods: Patients with abnormalities in the nerve conduction study constituted the polyneuropathy group, and patients without abnormalities formed the control group. When the laboratory values of the patients were analyzed, blood tests of 168 of 202 patients were reached. 117 of these patients had PNP and 51 did not have PNP. Results: In patients with PNP, glycolyzed hba1c ratio and fasting blood sugar were significantly higher than patients without PNP (p<.001). While HDL rate was lower in patients with PNP than those without PNP (p<0.01), TG/HDL ratio was higher (p<0.05). In patients with PNP, glycolyzed urea (p<0.001) and creatinine (p<0.01) were significantly higher than those without PNP. The serum level of 25(OH) vitamin D was significantly lower in patients with PNP than in patients without PNP (p<0.05). Ferritin was significantly higher in patients with PNP than patients without (p<0.01). Conclusions: Knowing and preventing risk factors for diabetic polyneuropathy, we can take a new direction to our treatment approaches and take early measures. Fasting blood sugar and hba1c control, regulation of lipid profile, monitoring of vitamin d and ferritin levels are particularly necessary for protection of polyneuropathy.